SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16539816
Source:
http://linkedlifedata.com/resource/pubmed/id/16539816
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003873
,
umls-concept:C0011306
,
umls-concept:C0039198
,
umls-concept:C0281481
pubmed:issue
1
pubmed:dateCreated
2006-3-16
pubmed:abstractText
To investigate whether anti-TNF therapy could have an effect on dendritic cells (DCs) and regulatory T cells in rheumatoid arthritis (RA) patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8308521
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines
,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/adalimumab
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed-author:AertsN ENE
,
pubmed-author:BridtsC HCH
,
pubmed-author:De ClerckL SLS
,
pubmed-author:DombrechtE JEJ
,
pubmed-author:HagendorensM MMM
,
pubmed-author:LamM TMT
,
pubmed-author:SchuerweghA JAJ
,
pubmed-author:StevensW JWJ
,
pubmed-author:Van OffelJ FJF
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16539816-Adult
,
pubmed-meshheading:16539816-Aged
,
pubmed-meshheading:16539816-Anti-Inflammatory Agents, Non-Steroidal
,
pubmed-meshheading:16539816-Antibodies, Monoclonal
,
pubmed-meshheading:16539816-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:16539816-Arthritis, Rheumatoid
,
pubmed-meshheading:16539816-Cell Separation
,
pubmed-meshheading:16539816-Cytokines
,
pubmed-meshheading:16539816-Dendritic Cells
,
pubmed-meshheading:16539816-Drug Therapy, Combination
,
pubmed-meshheading:16539816-Female
,
pubmed-meshheading:16539816-Flow Cytometry
,
pubmed-meshheading:16539816-Humans
,
pubmed-meshheading:16539816-Lymphocyte Activation
,
pubmed-meshheading:16539816-Male
,
pubmed-meshheading:16539816-Methotrexate
,
pubmed-meshheading:16539816-Middle Aged
,
pubmed-meshheading:16539816-Severity of Illness Index
,
pubmed-meshheading:16539816-T-Lymphocytes, Regulatory
,
pubmed-meshheading:16539816-Treatment Outcome
,
pubmed-meshheading:16539816-Tumor Necrosis Factor-alpha
pubmed:articleTitle
Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis.
pubmed:affiliation
Department of Immunology, Allergology and Rheumatology, University of Antwerp, Belgium.
pubmed:publicationType
Journal Article